16 May 2023
The CorFlow MOCA I Trial: learnings from the first-in-human direct measurement of microvascular obstruction in STEMI
Sponsored by CorFlow
Summary
To help you better understand the MOCA I Late-Breaking clinical Trial and its findings, follow this exchange between Rob Schwartz, Marco Valgimigli, and Azeem Latib.
What is this study about? What technology are we talking about exactly? Why is it important for clinical practice? How can we better diagnose and manage microvascular obstruction?
Follow this discussion to learn more about MVO, which is still a very important unmet clinical need when facing STEMI patients.
This interview was filmed at EuroPCR 2023: see more videos here!